Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Vancomycin-resistant enterococcus Stories

2012-04-10 06:28:38

NEW YORK, April 10, 2012 /PRNewswire/ -- MRSA--the super virulent bacteria that is a leading cause of infections during patient hospitalization--has met its match: Antimicrobial Copper. A live webcast experiment (http://www.antimicrobialtouchsurface.com/) demonstrated that Antimicrobial Copper effectively kills MRSA within two hours while it readily survives on stainless steel. "Antimicrobial copper is part of the solution in the fight against healthcare-acquired infections - it kills...

2011-11-01 09:24:30

Antibiotic-resistant enterococci are a serious problem for patients in the hospital, but little is known about how these bacteria are able to escape antibiotics. New discoveries about the ways in which enterococci turn their resistance to cephalosporin antibiotics on and off are described in a study that will be published November 1 in the online journal mBio®. The new details about resistance could lead to new therapies for preventing and treating enterococcal infections. Enterococcus...

2011-10-13 07:00:00

WATERTOWN, Mass., Oct. 13, 2011 /PRNewswire/ -- Enanta Pharmaceuticals, Inc., a clinical stage infectious disease biopharmaceutical company, announced today the award of a contract from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), worth up to $42.7 million over five years. The award will fund the preclinical and clinical development of a new class of bridged bicyclic antibiotics known as Bicyclolides to be used...

2011-08-12 06:50:00

MEMPHIS, Tenn., Aug. 12, 2011 /PRNewswire/ -- In an original article coauthored by John M. Boyce, MD; Nancy L. Havill, MT; and Brent A. Moore, PhD, "Terminal Decontamination of Patient Rooms Using an Automated Mobile UV Light Unit" (Infection Control and Hospital Epidemiology, August 2011), the research team from the Hospital of Saint Raphael and the Yale University School of Medicine ". . . demonstrated that an automated, portable UV light device significantly reduced aerobic colony counts...

2011-07-28 17:15:00

BOSTON, July 28, 2011 /PRNewswire/ -- TEI Biosciences Inc. announced today the market launch of PriMatrix(TM) Ag Antimicrobial Dermal Repair Scaffold, an acellular dermal tissue matrix incorporating ionic silver, for the management of wounds, ulcers and second degree burns. Ionic silver is a broad spectrum antimicrobial and in PriMatrix Ag it acts to inhibit microbial colonization of the tissue matrix. PriMatrix Ag has been shown in CLSI Disc Susceptibility testing to be effective...

2011-06-02 00:00:30

Decon ProGreen, LLC has developed a protocol called: "bio hazards & bed bugs" that kills MRSA, bed bugs, and their eggs using non toxic biodegradable solutions.This protocol is now available for licensed pest control applicators. (PRWEB) June 01, 2011 Even though there is no proven correlation between bed bugs and MRSA, an alarming amount of people bitten by bed bugs end up in the hospital with severe infections, MRSA being one of them. As reported by:...

6f6f01f50dce61ce4d046b454ee6eba7
2011-05-12 06:40:00

Despite the fact that bedbugs are generally not viewed as a major public health threat, drug-resistant staph bacteria has been found in bedbugs from three hospital patients from a subjugated neighborhood in Vancouver by a team of Canadian scientists. Although bedbugs are not known to spread disease, they do lead to scratching, which may cause the skin to tear and make people at risk for bacteria, said Dr. Marc Romney, an author on the study. A study published Wednesday in the journal...

2011-04-15 08:11:18

(Ivanhoe Newswire) --The current tactics hospitals are using to fight the spread of resistant bacteria in ICUs may not be working. A new multisite study led by the Mayo Clinic found that a commonly used strategy has not effectively helped to prevent the spread of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Thousands of Americans die from MRSA infections each year. Both MRSA and VRE are resistant to antibiotics and are difficult to treat if...

2011-04-14 12:28:44

NIH study evaluated 18 intensive care units WHAT: Expanded use of active surveillance for bacteria and of barrier precautions"”specifically, gloves and gowns"”did not reduce the transmission of two important antibiotic-resistant bacteria in hospital-based settings, according to a prospective, randomized clinical trial conducted in 18 intensive care units in the United States. Incomplete compliance by health care providers with recommended hand hygiene procedures and the use of...

2011-04-14 12:16:21

A new research study of the effect of a commonly used strategy to reduce the spread of antibiotic-resistant bacteria in hospital intensive care units (ICU) shows that the strategy had no significant effect. That's the surprising finding of a multisite study led by Mayo Clinic investigators. The bacteria -- methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE) -- are resistant to common antibiotics and harder to treat if patients become infected. The...


Latest Vancomycin-resistant enterococcus Reference Libraries

0_4d46cc72a490344d44ba78359f528175
2011-04-26 21:07:20

Enterococcus is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is a main constituent of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans, especially in the nosocomial environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of...

More Articles (1 articles) »